|
ZNF778 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67765801251107E-12 |
| Normal-vs-Stage2 |
5.72950020760743E-10 |
| Normal-vs-Stage3 |
8.89399665027213E-13 |
| Normal-vs-Stage4 |
2.21730001026543E-09 |
| Stage1-vs-Stage2 |
6.564800E-01 |
| Stage1-vs-Stage3 |
1.595820E-01 |
| Stage1-vs-Stage4 |
2.637700E-02 |
| Stage2-vs-Stage3 |
5.531200E-01 |
| Stage2-vs-Stage4 |
1.869190E-01 |
| Stage3-vs-Stage4 |
3.783200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.21120027738198E-10 |
| Normal-vs-Asian |
8.56092974288458E-12 |
| Caucasian-vs-AfricanAmerican |
6.065200E-01 |
| Caucasian-vs-Asian |
4.943200E-03 |
| AfricanAmerican-vs-Asian |
4.879700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
8.90959994670482E-09 |
| Male-vs-Female |
1.661650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.19519949492997E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.51054732558487E-12 |
| Normal-vs-Extreme_Obese |
9.00500000011739E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.479400E-01 |
| Normal_Weight-vs-Obese |
4.523000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.154000E-01 |
| Extreme_Weight-vs-Obese |
3.987500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.791400E-01 |
| Obese-vs-Extreme_Obese |
4.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.12709996891169E-09 |
| Normal-vs-Age(41-60Yrs) |
3.266897863341E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.61335397766516E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.882010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.026600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.907400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.323200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.053920E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.912200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.77302617032637E-13 |
| Normal-VS-KIRP CIMP |
1.41949999998836E-06 |
| Normal-VS-Unclassified PRCC |
2.41999999999187E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.305400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.026600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.651700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.973600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.160300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.579800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.22994972382185E-14 |
| Normal-vs-N2 |
6.19699999999668E-05 |
| N0-vs-N1 |
9.463600E-01 |
| N0-vs-N2 |
6.703600E-01 |
| N1-vs-N2 |
6.074400E-01 |
|
|
